People: Emergent BioSolutions Inc (EBS)

EBS on New York Consolidated

30.74USD
1 May 2015
Change (% chg)

$1.05 (+3.54%)
Prev Close
$29.69
Open
$29.80
Day's High
$30.89
Day's Low
$29.70
Volume
202,307
Avg. Vol
262,291
52-wk High
$31.33
52-wk Low
$19.31

Search Stocks

Kramer, Robert 

Mr.Robert G. Kramer Sr., is Executive Vice President - Corporate Services Division, Chief Financial Officer and Treasurer of Emergent BioSolutions Inc., effective from December 3, 2012. Mr. Kramer has served as executive vice president, corporate services division since September 2012 and as chief financial officer since December 2012. He is responsible for finance and administration, human resources, IT, investor relations, quality, regulatory affairs and medical affairs. Mr. Kramer joined Emergent in 1999 as our chief financial officer. From 1999 until his retirement in 2010, he held various executive positions with the last being president of Emergent Biodefense Operations Lansing LLC, one of wholly-owned subsidiaries. Mr. Kramer returned to the company in 2011 as the interim head of the Biosciences division, and then as interim executive vice president, corporate services division before taking his current position. Prior to joining Emergent in 1999, Mr. Kramer held various financial management positions at Pharmacia Corporation, which subsequently merged with the Upjohn Company in 1995 and eventually became part of Pfizer Inc. Mr. Kramer received an M.B.A. from Western Kentucky University and a B.S. in industrial management from Clemson University.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
659,510 -- 1,258,480 1,917,990

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Fuad El-Hibri

3,591,370

Daniel Abdun-Nabi

4,147,390

Robert Kramer

1,917,990

Adam Havey

1,241,980

Barry Labinger

1,298,660

Ronald Richard

--
As Of  30 Dec 2014
Search Stocks